Medpace Income Statement
MEDP / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
Medpace reported $2.5B in revenue and $451M in net income for FY2025. Revenue has grown at a 23.5% compound annual rate over the past 11 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.1B | $1.9B | $925.9M | $1.1B | $925.9M | $861.0M | $421.6M | $436.2M | $421.6M | $359.1M | $248.5M |
| SG&A Expense | $197.6M | $180.2M | $161.4M | $92.2M | $108.4M | $92.2M | $95.2M | $61.5M | $63.4M | $61.5M | $57.0M | $29.5M |
| Operating Income | $534.9M | $446.9M | $336.8M | $167.0M | $198.6M | $167.0M | $127.3M | $52.5M | $64.9M | $52.5M | $20.6M | $2.4M |
| Income Tax | $91.3M | $71.5M | $52.9M | $23.1M | $20.0M | $23.1M | $24.4M | $8.5M | $17.8M | $8.5M | $843.0K | -$6.7M |
| Net Income | $451.1M | $404.4M | $282.8M | $145.4M | $181.8M | $145.4M | $100.4M | $13.4M | $39.1M | $13.4M | -$8.7M | -$14.3M |
| EPS (Basic) | $9.20 | $7.57 | $5.06 | $4.07 | $2.79 | $2.05 | $1.00 | $0.38 | -$0.28 | -$0.46 | -$0.28 | -$0.46 |
| EPS (Diluted) | $8.88 | $7.28 | $4.81 | $3.84 | $2.67 | $1.97 | $0.98 | $0.37 | -$0.28 | -$0.46 | -$0.28 | -$0.46 |
| Shares Outstanding | 30.6M | 30.8M | 31.1M | 36.0M | 35.5M | 36.1M | 35.7M | 35.5M | 40.7M | 32.6M | 31.3M | 30.9M |
| Operating Margin | 21.1% | 21.2% | 17.9% | 18.0% | 17.4% | 18.0% | 14.8% | 12.4% | 14.9% | 12.4% | 5.7% | 1.0% |
| Profit Margin | 17.8% | 19.2% | 15.0% | 15.7% | 15.9% | 15.7% | 11.7% | 3.2% | 9.0% | 3.2% | -2.4% | -5.8% |